American Society Of Transplantation

Balance Sheet
Fiscal Year: 2024
Assets in 2024 (Year End)
$22,402,578
Investments
77%
Cash & Equivalents
16%
Other Assets
2%
Prepaid Expenses
2%
Receivables (Non-Related)
2%
Property, Plant, & Equipment (net)
1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$1,725,088
Deferred Revenue
66%
Payables & Accruals
18%
Other Liabilities
15%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$2,074,693
$3,564,211
+72%
Receivables (Non-Related)
$1,543,588
$342,049
-78%
Related-Party Receivables
-
$0
-
Inventories
-
$0
-
Prepaid Expenses
$735,770
$514,228
-30%
Investments
$16,807,978
$17,159,059
+2%
Property, Plant, & Equipment (net)
$185,518
$276,744
+49%
Other Assets
$523,248
$546,287
+4%
Total Assets
$21,870,795
$22,402,578
+2%
Liabilities
2023
2024
Change
Payables & Accruals
$527,273
$312,754
-41%
Grants Payable
-
$0
-
Deferred Revenue
$1,068,453
$1,145,318
+7%
Tax-Exempt Bond Liabilities
-
$0
-
Custodial & Escrow Liabilities
-
$0
-
Notes Payable / Debt (Non-Related)
-
$0
-
Related-Party Payables
-
$0
-
Other Liabilities
$329,621
$267,016
-19%
Total Liabilities
$1,925,347
$1,725,088
-10%
Net assets
2023
2024
Change
Restricted Net Assets
$1,344,551
$1,281,686
-5%
Unrestricted Net Assets
$18,600,897
$19,395,804
+4%
Net assets
2023
2024
Change
Net assets
+$19,945,448
+$20,677,490
+4%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)